Microbix Biosystms (TSE:MBX) has released an update.
Microbix Biosystems Inc., a Canadian life sciences company, is set to release its Q3 fiscal 2024 financial statements and management discussion analysis before trading begins on August 14, 2024. A webinar will follow, featuring key executives, to discuss the quarterly results. Microbix specializes in creating biological products for human health, including antigens for diagnostics and quality assessment products, and has recently aimed for monthly sales of C$ 2.0 million.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
